Loading
Latest filing published 12 Nov 2021 for IO Biotech, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Vanessa Malier in IO Biotech, Inc., where the filings describe the role as board member. Altogether 4 filings, all relating to 9 November 2021.
Purchases make up the whole of the open-market record (2 purchases, €3.9M). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 12 November 2021, the filings show an open-market purchase worth €2.0M in IO Biotech, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration